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Optimal hematocrit Ho maximizes oxygen transport. In healthy humans, the average hematocrit H is in
the range of 40-45%, but it can significantly change in blood pathologies such as severe anemia (low H) and
polycythemia (high H). Whether the hematocrit level in humans corresponds to the optimal one is a long
standing physiological question. Here, using numerical simulations with the Lattice Boltzmann method and two
mechanical models of the red blood cell (RBC) we predict the optimal hematocrit, and explore how altering
the mechanical properties of RBCs affects Ho. We develop a simplified analytical theory that accounts for
results obtained from numerical simulations and provides insight into the physical mechanisms determining
Ho. Our numerical and analytical models can easily be modified to incorporate a wide range of mechanical
properties of RBCs as well as other soft particles thereby providing means for the rational design of blood
substitutes. Our work lays the foundations for systematic theoretical study of the optimal hematocrit and its link
with pathological RBCs associated with various diseases (e.g. sickle cell anemia, diabetes mellitus, malaria,
elliptocytosis).
INTRODUCTION
Oxygen delivery to tissues is provided by red blood cells
(RBCs), which make up about 40− 45% of blood volume
(in the macrocirculation). A long standing question is the
existence of an optimal hematocrit (optimal volume percent-
age of RBCs), i.e., a hematocrit level above or below which
oxygen supply is impaired [1–8]. A hematocrit maximiz-
ing oxygen transport (i.e. a maximum in the dependence
of the RBC flow rate on hematocrit) is intuitively expected
based on the following argument: while increasing the hema-
tocrit increases the flux of oxygen-carrying RBCs, it reduces
blood flow rate because of increased flow resistance. Yet, the
value of the optimal hematocrit and the mechanisms control-
ling it are not known even though, given its medical impor-
tance, e.g., in blood transfusion, the topic has been exten-
sively discussed in the physiology and hemorheology litera-
ture [4, 8]. A very basic question, “why is the normal sys-
temic hematocrit in humans about 40−45%?”, lacks definite
answer. Moreover, since the hematocrit varies in the circu-
lation (e.g., it decreases in the microcirculation [9]), another
open question is “where in the circulation is the hematocrit
optimal?”. Solving these problems in silico is challenging
and highly non-trivial because of the complex nature of blood
flow: it involves many deformable RBCs moving and inter-
acting in blood vessels with complicated geometry [10–14].
Recent advances in computational power and novel simula-
tion approaches, however, are beginning to make the task
tractable and the bottom-up simulations of blood flow (by
explicitly accounting for blood elements) are becoming re-
alistic [14]. Computational approaches based on continuum
formulations [15–28] or particle-based models [29–35] have
been successfully applied to simulations of the flow of sin-
gle and many RBCs. These simulations have revealed that
many phenomena in blood flow such as platelet and leukocyte
margination, plasma skimming, clustering [9, 28, 36–40] have
a purely mechanistic origin. For example, plasma skimming
and hematocrit decrease in the microcirculation (Fa˚hræus-
Lindquist effect) [9] arise from a cross-streamline migration
of RBCs due to local flow perturbation by the deformable
RBC [16, 41, 42]. Many experiments have pointed to and
continue to reveal plethora of effects on the individual and
collective behaviors of RBCs under flow [12, 43–47].
In this work, we study the RBC flow rate as a function of
hematocrit, vessel size, and mechanical properties of RBCs.
We investigate this problem using both numerical simulations
and analytical studies covering a wide hematocrit range. In
the simulations we use two models for RBCs: (i) a 3D model
accounting for both bending energy and in-plane shear elas-
ticity, associated with the cytoskeleton (a network of proteins
lying beneath the RBC membrane), and solved by the Lattice
Boltzmann method (LBM), (ii) a 2D model based on the LBM
which accounts for membrane bending modes that shows the
same trends, offering a faster tool to explore in the future
wider ranges of parameters. We find that optimality cannot
be reached in all the vessels of the circulatory system at the
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FIG. 1. RBC flow rate QRBC/Q0 as a function of hematocrit Ht for a
channel width W = 40µm, according to experiment, 3D simulations,
and empirical Pries model. In the simulations, Cs = 0.18, the channel
width is 14.8 R, the channel length along the flow direction is about
11.7 R, and is equal to 6.2 R in the orthogonal direction.
same time and that for straight channels the optimal hema-
tocrit matches the actual hematocrit in the arterioles. For a
vessel network (mimicking the real vasculature), optimality
is reached between small arteries, about 1 mm of diameter,
down to large arterioles, in the range 100-200 µm (for hu-
mans the arteriole range is 10−200µm[48]). Interestingly, for
networks, the optimum occurs at the junction between macro-
circulation (small arteries) and microcirculations (arterioles).
This is interesting as a major proportion of oxygen consump-
tion is known to take place in arterioles [49], before reaching
capillaries.
RESULTS
We investigate first the existence of an optimal hematocrit
using numerical simulations with the LBM in 2D for compu-
tational efficiency, however, we also performed simulations in
3D to confirm that the behavior in 3D is qualitatively similar
to that in 2D. We simulate the flow in a straight channel of
length L and width W for several values of hematocrit Ht . The
channel widths range from W = 2R (capillary scale), where R
is the RBC effective radius, up to W = 64R (arteriole scale).
The capillary number ranges from 0.09 to 90 in 2D and from
0.2 to 0.9 in 3D. The capillary number is defined in 2D and 3D
as Ca = η〈γ˙〉R3/κ and Cs = η〈γ˙〉R/µs, respectively. The av-
erage shear rate 〈γ˙〉 is defined by 2Umax/W (Umax is the max-
imal velocity in the absence of red blood cells), κ and µs are
the bending and shear moduli of the RBC membrane, respec-
tively. In 3D, a capillary number based on shear elasticity can
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FIG. 2. Normalized RBC flow rate as a function of Ca for a channel
width W = 20µm. Reduced area is ν2D = 0.7.
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FIG. 3. Normalized RBC flow rate as a function of hematocrit for
channels with different widths. The red line indicates the Ht value
corresponding to a reservoir hematocrit of 45%. Ca = 0.9, and is
close to the values encountered in human arterioles. Reduced area is
ν2D = 0.7.
be estimated. Taking R ∼ 4µm, µs = 4µ N/m [50], typical
vessel diameters of human capillaries and arterioles (about 5-
10 µm and 10-200 µm respectively [48]) and typical maximal
velocities in capillaries and arterioles (1− 10mm/s) [51] one
finds an approximate range Cs = 0.1− 1. The reduced vol-
ume ν in 3D and the reduced area ν2D in 2D (see material and
method for their definition) are varied from about 0.6 (healthy
RBC value) up to 1 (sphere or circle) in order to explore their
influence, as several diseases (spherocytosis, ellipsocytosis)
correspond to high value of ν , close to one.
3A validation experiment is performed with RBCs extracted
from whole blood, and subject to a constant pressure differ-
ence. Unlike previous experimental studies [1, 2] the hema-
tocrit within the channel is extracted directly by light ab-
sorption techniques. This hematocrit is varied between 0.05
and 0.9 and the capillary number is estimated to be Cs =
0.01− 0.19. The microfluidic channel has rectangular cross
section with a thickness of 40 µm much smaller than the other
two dimensions.
Along this paper, we shall also refer to the predictions made
based on the empirical expression of healthy blood viscosity
[denoted ηp(Ht)], obtained by Pries et al. by data fitting [37]
(see SI).
Oxygen delivery is quantified by the RBC flow rate, QRBC
normalized by the flow rate of the cell-free fluid Q0 under
same pressure gradient. In the simulations, the flow rate QRBC
is calculated by counting the number of RBCs that cross a
given section in the channel, and after averaging over long
runs. The determination of QRBC in experiments is described
in SI. Figure 1 shows that QRBC/Q0 exhibits a maximum as
a function of hematocrit Ht . Similar results are found in ex-
periments and with the Pries et al. model [37], with an opti-
mal hematocrit about 0.4. In 3D simulations the optimum is
around 0.3.
Next, we investigate this phenomenon in more detail, fo-
cusing on the effects of flow strength (measured by the cap-
illary number) and channel width. The following simulations
are performed in 2D. Figure 2 shows that the maximum of
QRBC/Q0 is not very sensitive to the flow strength Ca: the op-
timal hematocrit Ho increases from 0.3 to about 0.4 over 3
orders of magnitude of increase in Ca. The slight increase in
Ho with Ca arises from the increased RBC deformation (see
below). Interestingly, as Ca approaches unity (values encoun-
tered in arterioles) Ho quickly saturates to a value slightly
larger than 0.4. Figure 3 illustrates the effect of channel
width on the optimal hematocrit. The results show that Ho
varies between 0.3 in large enough channels (W = 160µm) to
about 0.4 in smaller channels (W = 10µm).
Optimality occurs in the arteriole range for straight channels
In reality, the usual reference hematocrit of 0.4 and 0.45 for
women and men respectively corresponds to values encoun-
tered in macrocirculation (usually measured in medical blood
tests). It will be referred to as the reservoir hematocrit Hr.
This value decreases in the microcirculation due (in particu-
lar) to the Fa˚hræus effect [52]. This effect results from the
tendency of RBCs to accumulate in the center of the vessel,
acquiring thus a higher mean velocity than that of the plasma
and leading to a diluted flow in small vessels: Ht < Hr. In
a given simulation the channel width and the number of cells
are fixed, which corresponds to prescribing the tube hemat-
ocrit Ht . If 〈VRBC〉 denotes the mean velocity of RBC and 〈VT 〉
that of the whole suspension (RBCs plus the suspending fluid)
in the tube, the total flow rate of RBCs across a section A of
the tube is given by QRBC = 〈VRBC〉AHt and that of the whole
suspension is given by QT = 〈VT 〉A. The ratio of the QRBC
to QT provides the volume fraction of RBCs (or hematocrit)
found in large vessels at the exit, Hr (usually called reservoir
hematocrit). We have thus the following relation
Hr =
QRBC
QT
= Ht
〈VRBC〉
〈VT 〉 (1)
Thus, measuring 〈VRBC〉/〈VT 〉 in the simulation yields directly
the reservoir hematocrit. For each channel width, performing
simulation with different Ht , we can extract the relation be-
tween Hr and Ht (see Fig. S1 in SI). In large vessels (macro-
circulation) the RBCs are homogeneously distribuged within
the vessel section so that 〈VRBC〉 ' 〈VT 〉, implying Ht 'Hr. In
contrast, in microcirculation the tendency of RBCs to migrate
towards the vessel center means that 〈VRBC〉 > 〈VT 〉, imply-
ing that Ht < Hr. The red points in Figure 3 show the tube
hematocrit that would result from Hr = 0.45 reservoir (sys-
temic) hematocrit. The tube hematocrit Ht is superoptimal
in large enough channels (the red diamond in Figure 3 for
W = 160 µm and for larger channel widths – not shown here)
and approaches optimality for W = 40µm and W = 20 µm
(red upper triangle and red circle), which corresponds to the
small-to-medium diameter range of human arterioles. This is
interesting inasmuch as two thirds of the oxygen is known to
be delivered in the arteriolar trees [49] before reaching capil-
laries. This picture is also confirmed (see below) by using a
simplified model, and by using the Pries empirical model (see
Fig. 4), albeit with an optimum occurring for a slightly larger
vessel diameter (around 60µm). This value, as well as the
optimal one obtained in the simulations (Fig. 3), lies within
the arteriole range. On the contrary, in capillaries, the tube
hematocrit is slightly suboptimal for a reservoir hematocrit of
45%.
Analytical model
We develop an analytical model that captures the compu-
tational and experimental observations for the dependence
of QRBC on tube hematocrit Ht . This analytical model pro-
vides means for a quick estimate of the optimal hematocrit
and insight into the mechanisms that control the phenomenon.
We adopt the two-fluid model for blood flow: an inner core
containing a homogeneous suspension of volume fraction H
surrounded by a cell-free layer of thickness e, flowing in a
tube of radius R0 = W/2. For given tube hematocrit Ht ,
H = Ht × ( R0R0−e )2.
The RBC flux is
QRBC(Ht) = H
∫ R0−e
0
v(H,r)2pirdr, (2)
and the total flux is given by
QT (H) =
∫ R0
0
v(H,r)2pirdr (3)
4For a given pressure gradient (flow strength), the Stokes ve-
locity profiles v(H,r) in the outer cell-free annulus and in
the core can be evaluated. Assuming that the core fluid is
a homogeneous, dense suspension of concentration H, its
relative viscosity η¯ ≡ η(H)/η0 can be estimated from the
Krieger-Dougherty [53] law η¯ = (1−H/Hm)−[η ]Hm , where
the maximum fraction Hm = 1 (due to the fluid character of
the the RBC membrane and its flexibility), [η ] is the intrin-
sic viscosity, which is taken to be equal to 2.5, as for rigid
spheres, in this simplistic model, and η0 is the viscosity of
the cell-free plasma. The thickness of the near-wall cell-free
layer e decreases linearly as hematocrit increases [28, 54, 55]:
e = e0(1−Ht/Hm) where e0 is a constant characterizing the
cell-free layer at low hematocrit (taken as e0 = 2µm). Finally,
QRBC
Q0
=
QRBC
QT (H = 0)
=
H
(
R0− e
)2(R20+ (2η¯(H)−1)(2eR0− e2))
η¯(H)R40
,
(4)
where e and H are the functions of Ht given above.
Figure 5 illustrates the prediction of this reduced model. As
in simulations, it is seen that the optimal hematocrit increases
with the confinement, and so does the corresponding RBC
flux. Had we assumed a fixed cell-free layer, independent of
Ht , we would then have missed the fact (data not shown, see
also [4]) that optimal hematocrit increases with confinement.
The red line corresponds to the location of the tube hematocrit
if the reservoir hematocrit (i.e. the hematocrit in macrocircu-
lation) is equal to 0.45. Here again we find, as in direct sim-
ulation (Figure 3), that the optimal hematocrit corresponds to
a channel diameter of about 30 µm (red upper triangle in Fig.
5) meaning that optimality is reached in the arterial tree, and
not in capillaries.
Optimal hematocrit in vascular network
According to the simulations (Fig. 3) and the analytical re-
sults (Fig. 5 and Fig. 4A for a more quantitative analysis),
when the reservoir hematocrit is equal to 0.45, the tube ham-
atocrit in microcirculation goes down to about 0.3 (see red
lines in Fig. 3 and Fig. 4A). Experimental studies of tube
flow [6, 52, 56] yielded minimal values for the ratio Ht/Hr
of about 0.7 for tubes of 20 µm and 10 µm diameters, which
is consistent with this study which provides 0.3/0.45∼ 0.66.
However, in vivo studies [7, 57, 58] have shown that this ratio
can fall in the range 0.3-0.5 in the microcirculation. In vivo
measurements have suggested that this is dependent on net-
work topography and local flow rates. While, for that reason,
our study can not be directly applied to a vascular network, we
have attempted to analyze this issue on the basis of Pries em-
pirical model (see Fig. 4A) with the hope to get a more quanti-
tative result. We have considered the cases where the network
consists of N levels, where each tube of generation i with ra-
dius R(i) and length L(i) divides symmetrically into two chan-
W=10µm
W=15µm
W=30µm
W=60µm
W=200µm
W=1000µm
0 0.2 0.4 0.6 0.8 1
Hr
b=0.17
b=0.3
b=0.5
b=1.4
0
0.1
0.2
0.3
0.4
0 0.2 0.4 0.6 0.8 1
Q
R
BC
/Q
0
Ht
A B
Hr=45%
Ho
FIG. 4. A: The RBC flow rate as a function of tube hematocrit
for channels of different diameters calculated from Pries empirical
model; The red line indicates the Ht value corresponding to a reser-
voir hematocrit of 45%. B: The RBC flow rate for a model network
for different values of b extracted from literature. The curves are sim-
ilar to those for large channels that would be obtained from panel A
by considering Hr instead of Ht . Small values of b give more weight
to the smallest vessels, hence an increase of the optimal hematocrit.
Still, the contribution of large vessels is predominant.
nels of level i+1 with radius R(i+1) and length and L(i+1)
(see SI). R(i)1/a = 2R(i+ 1)1/a and L(i)1/b = 2L(i+ 1)1/b,
where a and b are exponents that can be obtained by fitting
in-vivo data [59]. This provides[59] the ranges 1/3−1/2 and
0.17− 1.4 for a and b, respectively. We considered a net-
work starting from a channel of about 1 mm with successive
bifurcations down to 5 µm. Taking a = 1/3 (consistent with
Murray’s law [60]) this analysis reveals (Fig. 4B) that the
dominant contribution arises from largest vessels of the net-
work. In other words, the overall efficiency of flow rate of
RBCs could be dictated by large vessels, despite the fact that
oxygen delivery takes place in microcirculation. This would
point to the fact that optimization of oxygen transport capac-
ity may be regulated upstream of the microcirculation, close
to the transition zone between small arteries and arterioles.
Caution is however necessary since the situation is less clear
for a= 1/2, for instance. In addition, a continuum model may
fail to describe the dynamics in small vessels of the networks
[47]. A systematic simulation taking into account the corpus-
cular nature of blood and the heterogeneities of networks are
necessary before making general conclusive answers.
Blood disorder
Blood disorders are known to affect blood flow and rheol-
ogy. Thus we have investigated the implication of some dis-
orders for the oxygen transport capacity. The first example
corresponds to patients suffering from low or high level of
hematocrit (anemia and polycythemia, respectively). An out-
standing feature emerges. Indeed, if the reservoir hematocrit
is small enough (Hr = 0.25), as happens in severe anemia dis-
ease – blue line in Fig. 5 –, or large enough (Hr = 0.8) as is
the case in polycythemia vera – green line in Fig. 5 –, then the
5tube hematocrit does not cross any optimal value. In the ane-
mia disease case the hematocrit remains suboptimal, while it
remains superoptimal in the polycythemia disease. In the first
case the attained flow rate in arterioles is about 25% lower
than in healthy subjects, while the situation is more severe in
the second case where the reduction can attain about 60%.
Other blood disorders are related to RBC shapes. For exam-
ple, in spherocytosis (a hereditary disease caused by molecu-
lar defects in several proteins of the cytoskeleton that can lead
to asthenia, polypnea, and an increased heart rate among other
symptoms) RBCs shape is close to a sphere, which quantita-
tively corresponds to reduced volume close to 1. Here the sim-
ulation is performed both in 2D (data not shown, same con-
clusions) and in 3D using the classical Skalak et al. model for
the cytoskeleton [61]. Figure 6 shows that a spherical shape of
the RBCs lowers both the optimal Ho and the maximum RBC
flow rate. For example, when the reduced volume ν passes
from 0.64 (healthy RBC) to 0.94 (close enough to a spherical
shape) the maximal carrying capacity drops by about 25 %.
The origin of this collapse is attributed to the fact that RBCs
are less deformable because of nearly spherical shape reduc-
ing their ability to squeeze and accommodate high H. More-
over, cross-stream migration is suppressed and the cell-free
layer diminishes leading to increased flow resistance. Both
effects (packing and cell-free layer thinning) contribute to a
collapse of the oxygen carrying capacity. Those effects can
be qualitatively included in our minimal model by modifying
accordingly the rheology law for the core or the cell-free layer
thickness. This leads to the same conclusion (see SI).
Finally, many pathologies are accompanied by an alteration
of the mechanical properties (e.g. shear elasticity) of the RBC
membrane. For example, in sickle cell and malaria diseases,
the RBC elastic modulus can be significantly higher (up to
about three times higher) than within healthy subjects. An
increase of the elastic modulus is equivalent to a decrease of
the capillary number. Our data in Fig. 2 show that a reduction
of the capillary number leads to a significant collapse of the
RBC flow rate.
Stretchable capsules boost the oxygen carrying capacity
A major branch of research in the context of blood substi-
tutes is directed towards hemoglobin encapsulation strategies.
It is put forward here that a slightly stretchable encapsulat-
ing membrane (like polymer-based capsules) would lead to a
significant enhancement of oxygen transport capacity. This
idea emerged from a numerical analysis of the role of mem-
brane compressional elasticity on the maximum hemoglobin
flow rate. Figure 7 (violet data) shows the results; the green
data correspond to incompressible membranes. In each simu-
lation we have selected an initial reduced volume ν = 1 (the
same for all cells) and performed several simulations, each
time with different elastic properties. Each cell within the
same uniform suspension (i.e. all cells have the same proper-
ties) experiences different shear stress and thus will be more or
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FIG. 5. The RBC flow rate as a function of tube hematocrit for chan-
nels with different diameter calculated from our minimal model. The
red line indicates the Ht value corresponding to a reservoir hemat-
ocrit Hr of 45% for the corresponding model. Blue and green lines
correspond to high Hr (80% , such as in polycytemia), and low Hr
(25 % for anemia).
less stretched. The average actual reduced volume within the
suspension is shown as a filled square, whereas the horizontal
bars show the distribution of reduced volume for each simu-
lation (i.e. for a given stretching elastic coefficient). One sees
that a moderate extensibility, allowing an average decrease of
the reduced volume of the capsules by as little as 10%, leads to
a maximum flow rate equivalent to that of healthy conditions,
even though the capsules are quasi-spherical. This result also
implies that if the blood substitute elements were biconcave,
a significantly lower hematocrit than 40− 45% can provide
the same oxygen carriage capacity. Membrane elasticity, even
when moderate, emerges thus as an important element for fu-
ture design of oxygen carrier materials.
CONCLUSION
Through intensive numerical 2D and 3D simulations we
provided information on the behavior of the RBC flow rate as
a function of hematocrit, which is directly linked to the oxy-
gen carriage capacity. Interestingly, the values obtained for
optimal hematocrit in our simulations for vessel sizes corre-
sponding to macrocirculation and intermediate microcircula-
tion (arterioles) are close enough to the corresponding physi-
ologically admitted values. Strong alterations are reported if
the reduced volume of RBCs is increased sufficiently, as is
known for elliptocytosis and spherocytosis diseases. Not only
is the flow rate of RBCs reduced in this case compared to the
flow of healthy RBCs at the same hematocrit but also the op-
timal hematocrit is observed to be significantly lower. The
lower value of RBC flow rate within patients suffering these
diseases implies a severe collapse of oxygen delivery, which
could lead to an increased heart load in order to maintain ap-
propriate perfusion levels. It is known that elliptocytosis and
spherocytosis diseases are accompanied by a reduction of the
RBC count. This might represent a natural adaptation that ac-
6FIG. 6. Left: The normalized RBC flow rate as a function of tube hematocrit for different reduced volumes. Viscosity contrast is 1 and the
channel width W is 40µm (other dimensions as in Fig. 1) and Cs = 0.18. A, B and C are snapshots of suspension configurations for the three
different reduced volumes shown for the corresponding optimal hematocrit.
FIG. 7. Green line: Optimal flux and optimal hematocrit as a func-
tion of the actual reduced volume (3D simulations) for incompress-
ible membranes. violet lines: the same simulation with stretchable
capsules. For each simulation the compressional elasticity has been
varied in order to allow for different average reduced volume 〈ν〉.
Each capsule experiences different shear stresses within the channel,
and has thus different surface area (and thus reduced volume); the
horizontal bars provide the distribution width of reduced volumes
within the same suspension. Cs = 0.18, as in Fig. 1
tually improves oxygen delivery. Stretchable membranes are
found to be a key element in boosting oxygen transport. This
study provides a more precise framework for predicting the
impact of several blood diseases on oxygen transport, and for
suggesting new paradigms in blood flow research. The infor-
mation generated by this study may guide the development of
new soft materials, such as blood substitutes, and advance the
tuning process and optimization of oxygen carriers.
MATERIALS AND METHODS
We represent RBCs as either a contour endowed with bend-
ing energy immersed in 2D fluid, or as a surface having both
bending energy and shear elasticity in a 3D fluid. The simula-
tion uses a 2D and 3D Lattice Boltzmann method. The bend-
ing energy is given by E = (κ/2)
∫
H2dA with H the mean
curvature, dA the arclength in 2D or area in 3D, and κ the
bending rigidity modulus. In 3D, the membrane has addition-
ally a shear elastic energy written as µs(I21 + 2I1− I2)/12+
κα I22/12, where µs is the shear elastic modulus and κα is the
area dilation modulus. I1 and I2 are the in-plane strain in-
variants (see [62]). κα/µs = 200 is chosen large enough to
preserve membrane area locally.
We impose a pressure difference ∆p between the inlet and
outlet of the channel. In the absence of RBCs the flow is
of a Poiseuille type. In 2D (3D) the hematocrit is defined
as Ht = NA/A (NV/V ) where N is the number of cells in
the channel, A the area of cell and V the volume, whereas A
and V designate the total area and volume of the channel. η
is taken as 1.2 m.Pa.s (plasma viscosity), and the enclosed
fluid within RBCs is taken to have the same viscosity. The
precise values of the viscosity contrast have little influence
on the results. We define the capillary number (which is a
measure of the flow strength over the RBC’s mechanical re-
sistance) associated with bending and shear elastic modes as
Cb = η〈γ˙〉R3/κ and Cs = η〈γ˙〉R/µs, with 〈γ˙〉 = 2Umax/W ,
where Umax is the maximum velocity in the channel in the ab-
sence of cells. We have taken κ ' 3 10−19 J and µs ' 4 µN/m.
We define (in 2D) the reduced area ν2D ≡ (A/pi)/(p/2pi)2
(with p the perimeter and A the enclosed area) and the reduced
volume (in 3D) ν ≡ [V/(4pi/3)]/[A/4pi]3/2. For a healthy
RBC ν ' 0.64. We define in 2D R = √A/pi , and in 3D
R = [3V/(4pi)]1/3 as the typical RBC radius. For a healthy
RBC we have R' 2.7µm.
For experiments RBCs were extracted from whole blood
by successive washes in PBS solution and centrifugation. Af-
ter each centrifugation, the supernatant was pipetted out and
PBS was added to refill the tube. The washing/centrifugation
cycle was repeated three times. After the RBCs were iso-
lated, an adequate quantity was pipetted and suspended in a
buffer solution having the same density as RBCs (137mL ul-
trapure water, 63mL Optiprep — a iodixanol solution from
Axis Shield —, 1 tablet of PBS, 198mg glucose, 200mg BSA,
density ρ ≈ 1.1 g·mL−1) to produce samples of hematocrits
7ranging from Hr ≈ 0.05 to 0.96 with no sedimentation. Those
reservoir hematocrits were measured using glass hematocrit
tubes and centrifugation (of samples diluted in buffer solu-
tions with no Optiprep). The tube hematocrit was determined
by light absorption techniques (see SI). A given pressure dif-
ference was applied corresponding to shear elasticity capil-
lary numbers (the most relevant one for RBC) in the range
Cs = 0.01− 0.19. The microfluidic channel has a rectangu-
lar cross section, with thickness W = 40 µm, whereas the two
other dimensions are comparably large (see SI). The RBCs
flow rate measurement is described in SI.
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9Supplemental material for: Predicting optimal hematocrit in silico
EXPERIMENTAL CONFIRMATION OF THE OPTIMUM
We describe a straightforward determination of the blood flux at constant pressure drop in a confined geometry, which confirms
the general trend that is observed in simulations.
Preparation of blood samples
Blood samples from healthy donors were obtained through the E´tablissement Franc¸ais du Sang (Grenoble, France) and stored
at 4◦C until use. Red blood cells (RBCs) were extracted from whole blood by successive washes in PBS solution and centrifuga-
tion. After each centrifugation, the supernatant was pipetted out and PBS was added to refill the tube. The washing/centrifugation
cycle was repeated three times. After the RBCs were isolated, an adequate quantity was pipetted and suspended in a buffer so-
lution having the same density as RBCs (137mL ultrapure water, 63mL Optiprep — a iodixanol solution from Axis Shield
—, 1 tablet of PBS, 198mg glucose, 200mg BSA, density ρ ≈ 1.1 g·mL−1) to produce samples of hematocrits ranging from
Hr ≈ 0.05 to 0.96 with no sedimentation. Those reservoir hematocrits were measured using glass hematocrit tubes and centrifu-
gation (of samples diluted in buffer solutions with no Optiprep).
Determination of tube hematocrit
Due to scattering, the absorption in a RBC suspension depends non-linearly on the hematocrit [63]. A calibration procedure
is required to measure the absorption coefficient at known hematocrits. For each sample of measured hematocrit Hr, as well as
for the suspending iso-dense solution, a small drop is deposited at the center of a PDMS pool of same height as the channel, a
glass coverslip is placed on top of the pool and its contour pressed to adhere to the glass. Images are then acquired at different
positions to account for possible inhomogeneities. This provides a calibrated relationship between the absorption coefficient
− log
(
I(Hr)
I(Hr=0)
)
and H, where I(Hr) is the average light intensity in the image field for a suspension of hematocrit Hr and
I(Hr = 0) corresponds to the iso-dense solution.
In order to use the calibration curve, the optical parameters are kept strictly identical during the flow experiments (diaphragm
aperture, lightning conditions, light condenser position, camera parameters). Additionally, we checked that the behaviour of
the absorption coefficient was similar when using different blood samples, although due to the intrinsic variability in biological
samples, it was necessary to repeat the calibration experiment for each blood sample.
Interestingly, the relationship between Ht and Hr that we determined in the flat channel of thickness 40 µm that we use in
the following shows a good agreement with the empirical model of Pries et al. [64] that was proposed for a cylindrical tube of
diamter 40 µm (see Fig. S1).
RBC flux
The RBC flow rate is measured by using a co-flow geometry [65, 66]. A microfluidics circuit is built through standard soft
lithography techniques. The geometry of the co-flow channel of thickness 40 µm is illustrated in Fig. S2. Two inlet channels
(width 500 µm) are connected to a central co-flow channel (width Wtot = 1000 µm, length 1cm). In one of the inlet channels, an
iso-dense solution is injected at flow rates Qnewt imposed by a syringe pump ; in the other channel, RBC suspensions are injected
at flow rates QT controlled by another syringe pump.
In this co-flow geometry with a large aspect ratio, the pressure drop can be written as ∆PL ∝
Qi ηi
Wi
, where the subscript i refers
either to one of the two fluids (RBC suspension or Newtonian iso-dense solution) and Wi is the width occupied by fluid i. The
pressure drop is kept constant over the course of an experimental run by keeping the flow rate Qnewt constant and by adjusting
the flow rate of the RBC suspensions QT to keep the widths Wi constant for all samples of different hematocrits. For the first
sample, Qnewt and QT are chosen to provide a low enough velocity for the RBC suspension (of the order of mm · s−1, Qnewt
between 1 and 3 µL/min.) and a width ratio Wnewt/WRBC close to 1. This procedure allows us to keep the pressure drop constant
along an experimental run without measuring it directly, by simple optical determination of the flow widths. QT is then given by
the value that was set on the syringe pump. It also ensures that the reference flow rate Q0 (flow without cells) is equal to Qnewt.
The measured quantities Hr, Ht and QT are then combined to plot QRBC/Q0 =HrQT/Qnewt as a function of Ht , as in Fig. S3.
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FIG. S1. Black dots: Tube hematocrit Ht determined by light absorption versus reservoir hematocrit Hr in the flat channel of thickness 40 µm.
The open circles show the 3D numerical results. The dashed dark grey line is a guide to the eye of slope unity, the solid light grey line is the
empirical relation from Ref. [37] in a tube of diameter D = 40 µm.
FIG. S2. Illustration of the co-flow geometry at the entrance of the co-flow region.
PRIES EMPIRICAL MODEL
Pries et al. considered in [37] a fit of experimental data to propose empirical relationship between the effective viscosity of
blood in a cylindrical tube of diameter D and the tube hematocrit Ht , as well as between this tube hematocrit and the reservoir
hematocrit Hr. Both functions ηp(Ht) and Hr(Ht) are given in [37]. The relative RBC flow rate at constant pressure drop is then
given by QRBC/Q0 = Hr(Ht)×
ηp(Ht=0)
ηp(Ht ) .
MINIMAL MODEL
We derive more data from the minimal model used to identify the minimal ingredients necessary to understand the dependency
of the RBC flow rate on the hematocrit, the channel size, but also with the RBC properties.
We consider a cylindrical channel of radius R0 =W/2 with an outer ring of thickness e where a fluid of viscosity 1 flows.
In the core flows an homogeneous suspension of concentration H and viscosity η(H) = (1−H/Hm)−[η ]Hm , where Hm is the
maximum volume fraction and [η ] the intrinsic viscosity.
As discussed in the main paper, e is, in a first approximation, independent from W and decreases linearly with increasing
hematocrit. Self-consistency imposes then that e = e0(1−Ht/Hm) , where Ht = H× (R0−eR0 )2 is the tube hematocrit. QRBC/Q0
as a function of the tube hematocrit is given in the main paper.
Here we exploit further the results of this simplified model to help proposing scenarios on the basis of our minimal model for
the evolution of the optimal hematocrit with some cell mechanical properties: see Fig. S4. For considering more deformable
cells, a configuration which is classically explored by increasing the viscosity of the suspending fluid [55, 67–70], one expects
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FIG. S3. Reduced RBC flow rate as a function of tube hematocrit in a flat channel of thickness 40 µm. The dashed line is calculated using the
empirical Pries model.
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FIG. S4. RBC flux according to our minimal model. The reference configuration is W = 30 µm (left) or W = 1000 µm (right) , e0 = 2 µm,
[η ] = 5/2 and Hm = 1. Top panel: e0 is varied ; middle panel: [η ] is varied ; bottom panel: Hm is varied.
the size of the cell free layer to increase [55]. Also, the intrinsic viscosity would generally decrease, apart around the transition
between tumbling and tank-treading regime, as shown in [67]. As seen in Fig. S4, both effects lead to an increase of the optimal
hematocrit (except for large vessels for which the change in cell free layer size has no effect).
As discussed in the main paper, the evolution of the optimal hematocrit with the reduced volume can be understood by using
our minimal model. If one now considers less deflated cells, the intrinsic viscosity is not expected to vary that much since it
is equal to 5/2 for spheres and close to that value for RBCs. On the other hand, inflating cells would lead to a decrease of the
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maximal packing fraction Hm, which leads to a decrease of the optimal hematocrit. Inflating cells would also lead to a decrease
of the size of the cell free layer, which also leads to a decrease of the optimal hematocrit and of the associated RBC flux.
OPTIMAL HEMATOCRIT IN VASCULAR NETWORK
We consider a simplified network consisting of N levels enumerated as i = 1...N. Level 1 consists of one straight cylindrical
channel. Each channel of level i has radius R(i) and length L(i). It divides symmetrically into two channels of level i+ 1. At
each step, the RBC and plasma fluxes also split symmetrically, so that Hr is a conserved quantity. We consider a fixed pressure
drop ∆P between the inlet of the level-1 channel and the outlets of the level-N channels. Assuming bifurcation junctions do not
contribute to pressure drop, one straightforwardly obtains:
QRBC = HrQT = Hr∆P×
{ N
∑
i=1
2−i+1
8L(i)η(Hr,R(i))
piR(i)4
}−1
. (S1)
It is seen that the contribution of each channel depends on the detailed evolution of lengths and radii along the network.
Recently, the relationships between radii R(i) and lengths L(i) currently proposed in the literature have been discussed in detail
using a statistical analysis based on 3D imaging in human subjects [59]. Adapted to our case of dichotomous and symmetric
branching, these relationships can be written as R(i)1/a = 2R(i+1)1/a and L(i)1/b = 2L(i+1)1/b, where a and b are exponents
that can be extracted from fitting of in-vivo data. Using the recursive formulae R(i) = 2−a(i−1)R(1) and L(i) = 2−b(i−1)L(1) we
find:
QRBC = Hr
piR(1)4∆P
8L(1)
×{ N∑
i=1
2(4a−b−1)(i−1)η(Hr,R(i))
}−1
. (S2)
The factor 2(4a−b−1)(i−1) thus expresses the relative contribution from level i. According to [59], a value for a in the range
1/3−1/2 yields a good description of real data, with a = 1/3 for small vessels (R < 1 mm) and a = 1/2 for large vessels. An
exponent-based scaling for the lengths is not as strongly supported by the data, since different measurements yield exponent b
in the range 0.17− 1.40. However, it is interesting to observe that for a and b within the aforementioned ranges, the exponent
4a−b−1 can be either negative or positive, indicating that the major contributions can come from large or from small vessels
depending on the exponent sign. Since the effective viscosity significantly depends on the tube radius only when the radius is
smaller than about 1 mm [64], we focus on the case a = 1/3, which is also consistent with the Murray’s law [60]. In that case, a
realistic network geometry is likely to fall within a category where 4a−b−1 = 1/3−b < 0 (since this is consistent with most
available data for b). This result implies that more weight is attributed to wide vessels, yielding thus an optimal hematocrit H0
around known physiological values (see Fig. 7B in the main paper). Interestingly, this would point to the fact that optimization
of oxygen transport capacity may be regulated upstream of the capillaries, where blood gas exchanges with tissues and organs
takes place. However, given the dispersion of experimental data, the possibility for a positive exponent 4a−b−1 = 1/3−b is
not to be excluded, in which case narrow channels would have more weight than larger vessels. A systematic analysis of the
vessel size distribution in organs is needed before drawing more conclusive answers.
